Nadex Advertisement
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Mediwound Ltd (MDWD)

Add MDWD Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 2/1/2016 3:12:46 PM - Followers: 2 - Board type: Free - Posts Today: 0

MediWound Ltd. is a biotechnology niche specialty company focused on developing, manufacturing and globally commercializing innovative products that address unmet needs in the fields of severe burn and chronic wound management. MediWound’s goal is to provide healthcare professionals and patients with its innovative, burn wound eschar removal agent, NexoBrid™ NexoBrid™ successfully completed clinical development in hospitalized burn wounds and is approved and ready to launch in Europe.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MDWD News: Report of Foreign Issuer (6-k) 07/19/2017 04:21:09 PM
MDWD News: BARDA Upsizes Contract with MediWound and Exercises Option to Fund Further NexoBrid® Indications 07/19/2017 04:15:00 PM
MDWD News: BARDA Gives Notice of Intent to Exercise First Contract Option to Further Fund MediWound’s NexoBrid® Development 06/23/2017 08:26:58 AM
MDWD News: Report of Foreign Issuer (6-k) 06/22/2017 04:16:16 PM
MDWD News: Independent Study in Germany Shows NexoBrid® Reduces Average Burn Treatment Costs by nearly 30% Versus Standard of Care 06/16/2017 08:00:00 AM